The C/C-13910 genotype of adult-type hypolactasia is associated with an increased risk of colorectal cancer in the Finnish population

Gut

Volumn 54, Issue 5, 2005, Pages 643-647

  Rasinpera H ^b   Forsblom, C ^a   Enattah, N S ^c   Halonen, P ^d   Salo, K ^e   Victorzon, M ^e   Mecklin, J P ^f   Jarvinen H ^a   Enholm, S ^b   Sellick, G ^g   Alazzouzi, H ^h   Houlston, R ^g   Robinson, J ⁱ   Groop, P H ^a   Tomlinson, I ^j   Schwartz Jr , S ^h   Aaltonen, L A ^b   Jarvela I ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

^e VAASA CENTRAL HOSPITAL   (Finland)

^f JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

^g INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^h HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

ⁱ ST MARK S HOSPITAL   (United Kingdom)

^j IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FINLAND; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION RISK; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; FINLAND; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GREAT BRITAIN; HUMANS; LACTASE; MALE; MIDDLE AGED; NEOPLASM STAGING; NUTRITION PHYSIOLOGY; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SPAIN;

EID: 20244378667     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2004.055939     Document Type: Article

References (40)

1. Potter JD. Colorectal cancer: molecules and populations. J Natl Cancer Inst 1999;91:916-32.
2. Semenza G, Auricchio S, Mantei N. Small-intestinal disaccharidases. In: Scriver CR, Beaudet AL, Sly D, et al. The metabolic and molecular basis of inherited disease, vol 1. New York: McGraw-Hill, 2001:1623-50.
3. Järvinen R, Knekt P, Hakuljnen T, et al. Prospective study on milk products, calcium and cancers of the colon and rectum. Eur J Clin Nutr 2001;55:1000-7.
4. Norat T, Riboli E. Dairy products and colorectal cancer. A review of possible mechanisms and epidemiological evidence. Eur J Clin Nutr 2003;57:1-17.
5. Pietinen P, Malila N, Virtanen M, et al. Diet and risk of colorectal cancer in a cohort of Finnish men. Cancer Causes Control 1999;10:387-96.
6. Kearney J, Giovannucci E, Rimm EB, et al. Calcium, Vitamin D, and dairy foods and the occurrence of colon cancer in men. Am J Epidemiol 1996;143:907-17.
7. Ma J, Giovannucci E, Pollak M, et al. Milk intake, circulating levels of insulin-like growth factor-I, and risk of colorectal cancer in men. J Natl Cancer Inst 2001;93:1330-6.
8. Lamprecht SA, Lipkin M. Cellular mechanisms of calcium and vitamin D in the inhibition of colorectal carcinogenesis. Ann N Y Acad Sci 2001;952:73-87.
9. Holt PR. Dairy foods and prevention of colon cancer: human studies. J Am Coll Nutr 1999;18(suppl 5):379-91.
10. Bostick RM, Potter JD, Sellers TA, et al. Relation of calcium, vitamin D, and dairy food intake to incidence of colon cancer among older women. The Iowa women's health study. Am J Epidemiol 1993;137:1302-17.
11. Tsuda H, Sekine K, Ushida Y, et al. Milk and dairy products in cancer prevention: focus on bovine lactoferrin. Mutat Res 2000;462:227-33.
12. Parodi PW. Conjugated linoleic acid and other anticarcinogenic agents of bovine milk fat. J Dairy Sci 1999;82:1339-49.
13. Arola H. Diagnosis of hypolactasia and lactose malabsorption. Scand J Gastroenterol 1994;202(suppl):26-35.
14. Enattah NS, Sahi T, Savilahti E, et al. Identification of a variant associated with adult-type hypolactasia. Nat Genet 2002;30:233-7.
15. Kuokkanen M, Enattah NS, Oksanen A, et al. Transcriptional regulation of the lactase-phlorizin hydrolase gene by polymorphisms associated with adult-type hypolactasia. Gut 2003;52:647-52.
16. Nilsson TK, Johansson CA. A novel method for diagnosis of adult hypolactasia by genotyping of the -13910 C/T polymorphism with pyrosequencing technology. Scand J Gastroenterol 2004;39:287-90.
17. Rasinperä H, Savilahti E, Enattah NS, et al. A genetic test, which can be used to diagnose adult-type hypolactasia in children. Gut 2004;53:1571-6.
18. Olds LC, Sibley E. Lactase persistence DNA variant enhances lactase promoter activity in vitro: functional role as a cis regulatory element. Hum Mol Genet 2003;12:2333-40.
19. Troelsen JT, Olsen J, Møller J, et al. An upstream polymorphism associated with lactase persistence has increased enhancer activity. Gastroenterology 2003;125:1686-94.
20. Enattah NS, Forsblom C, Rasinperä H, et al. The genetic variant of lactase persistence C (-13910) T as a risk factor for type I and II diabetes in the Finnish population. Eur J Clin Nutr 2004;58:1319-22.
21. Suomalainen A, Syvänen AC. Quantitative analysis of human DNA sequences by PCR and solid-phase minisequencing. Mol Biotechnol 2000;15:123-31.
22. Ferguson A, MacDonald DM, Brydon WG. Prevalence of lactase deficiency in British adults. Gut 1984;25:163-7.
23. Ho MW, Povey S, Swallow D. Lactase polymorphism in adult British natives: estimating allele frequencies by enzyme assays in autopsy samples. Am J Hum Genet 1982;34:650-7.
24. Guix Garcia J, Rodrigo Gomez JM, Aporisi Querada L, et al. Intolerancia a la lactasa en la poblacion esponola. Rev Esp Enferm Apar Dig 1974;42:367-82.
25. Pena Yanez A, Pena Angulo JF, Juarez Fernandez C. Malabsorción de lactasa en estudiantes esponoles. I. Toleranzia intestinal a la sobrecarga oral de lactasa. Rev Esp Enferm Apar Dig 1971;35:925-38.
26. The World Dairy Situation 2002. Bulletin of the International Dairy Federation #379/2002.
27. Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2000: Cancer incidence, mortality and prevalence worldwide, version 1.0. IARC CancerBase No. 5. Lyon, IARCPress, 2001 (http://www-dep.iarc.fr/globocan/globocan.htm).
28. Carroccio A, Montalto G, Cavera G, et al. Lactose intolerance and self-reported milk intolerance: relationship with lactose maldigestion and nutrient intake. J Am Coll Nutr 1998;17:631-6.
29. de Vrese M, Stegelmann A, Richter B, et al. Probiotics - compensation for lactase insufficiency. Am J Clin Nutr 2001;73(suppl 2):421-9.
30. Obermayer-Pietsch BM, Bonelli CM, Walter DA. Genetic predisposition for adult lactose intolerance and relation to diet, bone density, and bone fractures. J Bone Miner Res 2004;19:42-7.
31. Ito M, Kimura M. Influence of lactose on faecal microflora in lactose maldigesters. Microbiol Ecol Health Dis 1993;6:73-6.
32. Robertson AM. Roles of endogenous substances and bacteria in colorectal cancer. Mutat Res 1993;290:71-8.
33. Szilagyi A. Redefining lactase as a conditional prebiotic. Can J Gastroenterol 2004;18:163-7.
34. Moore WEC, Moore LH. Intestinal floras of populations that have a high risk of colon cancer. Appl Environ Microbiol 1995;61:3202-7.
35. MacLennan R, Jensen OM. Dietary fibre, transit-time, foecal bacteria, steroids and colon cancer in two Scandinavian populations. Report from the International Agency for Research on Cancer Intestinal Microecology Group, Lancet 1977;8031:207-11.
36. Goossens D, Jonkers D, Stobberingh E, et al. Probiotics in gastroenterology: indications and future perspectives. Scand J Gastroenterol 2003;239(suppl):15-23.
37. Evans RC, Fear S, Ashby D, et al. Diet and colorectal cancer: an investigation of the lectin/galactose hypothesis. Gastroenterology 2002;122:1784-92.
38. Desilets DJ, Davis KE, Nair PP, et al. Lectin binding to human colonocytes is predictive of colonic neoplasia. Am J Gastroenterol 1999;94:744-50.
39. Irimura T, Matsushita Y, Sutton RC, et al. Increased content of an endogenous lactose-binding lectin in human colorectal carcinoma progressed to metastatic stages. Cancer Res 1991;51:387-93.
40. Loton R, Matsushita Y, Ohannesian D, et al. Lactose-binding lectin expression in human colorectal carcinomas. Relation to tumor progression. Carbohydr Res 1991;213:47-57.